Myomo (MYO) Enterprise Value Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -50.97% |
| Sep 30, 2025 | -19.26% |
| Jun 30, 2025 | -15.71% |
| Mar 31, 2025 | -23.65% |
| Dec 31, 2024 | -17.59% |
| Sep 30, 2024 | 17.82% |
| Jun 30, 2024 | 13.28% |
| Mar 31, 2024 | 14.24% |
| Dec 31, 2023 | 10.19% |
| Sep 30, 2023 | 5.83% |
| Jun 30, 2023 | -3.52% |
| Mar 31, 2023 | 12.29% |
| Dec 31, 2022 | -6.18% |
| Sep 30, 2022 | -19.57% |
| Jun 30, 2022 | -15.35% |
| Mar 31, 2022 | -11.91% |
| Dec 31, 2021 | -33.39% |
| Sep 30, 2021 | -11.50% |
| Jun 30, 2021 | -5.64% |
| Mar 31, 2021 | -7.16% |
| Dec 31, 2020 | 1.88% |
| Sep 30, 2020 | -39.01% |
| Jun 30, 2020 | -14.71% |
| Mar 31, 2020 | -158.23% |
| Dec 31, 2019 | -77.60% |
| Sep 30, 2019 | -106.27% |
| Jun 30, 2019 | -117.95% |